Registry
Aggregated from Health Canada enforcement notices, accredited laboratory COAs, and independent testing sources. Free to access.
| Compound / Product | Operator | NPN Status | ICPS Status | Assessed | Source |
|---|---|---|---|---|---|
| Injectable Peptide Drugs (multiple) Unauthorized injectable products including BPC-157 and TB-500. Sold online without DIN or NPN. |
Canlab Research | No Licence | Critical | Aug 2025 | Health Canada |
| Injectable Peptide Drugs (multiple) Unauthorized injectable peptide drugs sold online. Health Canada seizure and enforcement notice issued. |
Prime Research | No Licence | Critical | Apr 2025 | Health Canada |
| Semaglutide (injectable) Compounded semaglutide products sold without Health Canada authorization. Risk of dosing errors and contamination. |
Operator Under Review Pending | No Licence | High Risk | 2025 | Health Canada |
| Weight Loss Supplement (undeclared ingredient) Undeclared pharmaceutical ingredient (sibutramine) identified in natural health product. Product recalled. |
Operator Under Review Pending | Revoked | High Risk | 2025 | Health Canada |
| Testosterone Booster (lapsed NPN) Product continued to be sold after NPN lapsed. No current authorization on LNHPD. |
Operator Under Review Pending | Lapsed | Moderate | 2025 | LNHPD |
Displaying active findings. Registry is being populated. Data updated continuously as sources are verified. Submit a source